Volver a Agenda
Session Chair(s)
Jessica Voqui, PHARMD, MS
Regulatory Review Officer, Study Endpoints and Labeling Development, CDER
FDA, United States
Speaker(s)
Spoke 2 (continued)
Jeremy Hobart, PHD, FRCP
Peninsula College of Medicine and Dentistry, United Kingdom
Professor, Clinical Neurology and Health Measurement
Panel Discussion Moderator
Jessica Voqui, PHARMD, MS
FDA, United States
Regulatory Review Officer, Study Endpoints and Labeling Development, CDER
Panelists
Jeremy Hobart, PHD, FRCP
Peninsula College of Medicine and Dentistry, United Kingdom
Professor, Clinical Neurology and Health Measurement
Ashley F. Slagle, PHD, MS
Aspen Consulting, LLC, United States
Principal, Scientific and Regulatory Consulting
James P. Stansbury, PHD, MPH
FDA, United States
Social Science Analyst, Division of Non-Prescription Clinical Evaluation, CDER
Cynthia A Bens
Personalized Medicine Coalition, United States
Senior Vice President, Public Policy
¿Tiene una cuenta?